MDSCs also express high levels of VEGFR2, which, activated by VEGF secreted either by tumor cells or by themselves, lead to a vicious cycle that contributes to maintaining MDSCs angiogenic activity (Min et al., 2017). This evidence concerns the gene VEGFA and neoplasm.